^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SCRI-huCAR19v2

i
Other names: SCRI-huCAR19v2
Associations
Trials
Company:
Seattle Children's Hospital
Drug class:
CD19-targeted CAR-T immunotherapy, HER2-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials